Stock Information
MapLight Therapeutics Inc (MPLT)
Ticker Symbol: MPLT
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $960.55 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): N/A
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: N/A%
Latest News
-
MapLight Therapeutics to Participate in Upcoming Investor Conferences
Fri, May 8, 2026 7:01 AM
-
This Prudential Financial Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Mon, May 4, 2026 9:19 AM
-
This First Tracks Biotherapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday
Mon, May 4, 2026 7:40 AM
-
HC Wainwright & Co. Initiates Coverage On MapLight Therapeutics with Buy Rating, Announces Price Target of $45
Mon, May 4, 2026 7:02 AM
-
MapLight Therapeutics Completes Enrollment In Its Phase 2 Zephyr Trial Evaluating Ml-007C-MA For The Treatment Of Schizophrenia
Fri, May 1, 2026 7:06 AM
-
MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results
Fri, May 1, 2026 7:00 AM
Key Financials
Financial data not available
